Meglumine Antimonate: A Key Compound in Pharmaceutical and Emerging Electronic Applications

Exploring the properties, uses, and potential of Meglumine Antimonate (CAS 133-51-7) for diverse industrial needs.

Get a Quote & Sample

Advantages of Using Meglumine Antimonate

Proven Therapeutic Efficacy

Leverage the established effectiveness of meglumine antimonate in combating parasitic infections like leishmaniasis, a critical aspect for pharmaceutical suppliers.

Versatile Formulation Properties

Benefit from the compound's physical form and solubility, facilitating its use in various dosage forms, potentially supporting complex pharmaceutical manufacturing processes.

Emerging Industrial Applications

Investigate the potential of meglumine antimonate in new fields, such as electronic chemicals and photoresist applications, offering opportunities for diversification.

Key Applications

Leishmaniasis Treatment

Meglumine antimonate is a cornerstone treatment for leishmaniasis, an infectious disease caused by protozoan parasites, showcasing its significant medical value and demand in the pharmaceutical sector.

Antiprotozoal Agent Research

The inherent antiprotozoal properties of antimony compounds, exemplified by meglumine antimonate, make it a subject of interest for further research in developing new antiparasitic drugs.

Potential in Electronic Chemicals

While primarily pharmaceutical, its classification under electronic chemicals suggests emerging applications. Research into meglumine antimonate electronic chemicals could unlock new markets.

Photoresist Formulations

Its presence in photoresist chemical categories indicates potential use in microelectronics or lithography, a growing area where specialized chemical compounds are essential.